TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/7/24 21:40 | 3/5/24 | NTRA | Natera, Inc. | DE | Health | Health | Medical Laboratories | Rabinowitz Matthew | TX | DO | Exec CB | S | -16,694 | 87.40 | 0 | -191 | -9 | 1,936 | M | ||||||||||||||
3/24/23 21:35 | 3/22/23 | NTRA | Natera, Inc. | DE | Health | Health | Medical Laboratories | Rabinowitz Matthew | TX | DO | Exec CB | S.dm | -147 | 56.31 | 0 | -3 | 0 | 1,674 | D | ||||||||||||||
1/4/23 21:05 | 1/3/23 | NTRA | Natera, Inc. | DE | Health | Health | Medical Laboratories | Rabinowitz Matthew | TX | DO | Exec CB | S.d | -107 | 39.55 | 0 | -3 | 0 | 1,673 | D | ||||||||||||||
10/15/21 19:02 | 10/14/21 | NTRA | Natera, Inc. | DE | Health | Health | Medical Laboratories | Rabinowitz Matthew | TX | DO | Exec CB | S.d | -14 | 112.19 | 0 | 0 | 0 | 1,236 | D | ||||||||||||||
9/24/21 21:21 | 9/23/21 | NTRA | Natera, Inc. | DE | Health | Health | Medical Laboratories | Rabinowitz Matthew | TX | DO | Exec CB | S.d | -20 | 125.67 | 0 | 0 | 0 | 1,236 | D | ||||||||||||||
9/13/21 20:34 | 9/10/21 | NTRA | Natera, Inc. | DE | Health | Health | Medical Laboratories | Rabinowitz Matthew | TX | DO | Exec CB | S.d | -105 | 119.53 | 0 | -1 | 0 | 1,236 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |